{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:21:06Z","timestamp":1788283266098,"version":"build-2803163510"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>\n                    Constitutional mismatch repair deficiency (CMMRD) is an autosomal recessively inherited childhood cancer predisposition syndrome results from biallelic germline mutations affecting the key DNA mismatch repair gene: MLH1, MSH2, MSH6, or PMS2. CMMRD is associated with a high risk of developing early onset of central nervous system tumors, hematologic, and intestinal tract tumors. Clinical manifestations, genetic screening, and cancer prevention strategies are limited. In this report we present a patient with metachronous Wilms tumor, glioblastoma, and acute T-cell lymphoblastic leukemia. He had cutaneous features of neurofibromatosis type 1 (NF1). Molecular testing revealed a novel homozygous mutation in\n                    <jats:italic toggle=\"yes\">MSH6<\/jats:italic>\n                    (c.2590G&gt;T; p.G864\n                    <jats:sup>*<\/jats:sup>\n                    ) that has not been reported previously. CMMRD should be considered in patients with cutaneous features similar to NF1 if tumor is found other than expected tumors in NF, early onset cancer, and strong family history of cancer.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000001687","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T11:13:41Z","timestamp":1575890021000},"page":"e198-e202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Metachronous Wilms Tumor, Glioblastoma, and T-cell Leukemia in an Child With Constitutional Mismatch Repair Deficiency syndrome due to Novel Mutation in MSH6 (c.2590G&gt;T)"],"prefix":"10.1097","volume":"43","author":[{"given":"Elvan C.","family":"Citak","sequence":"first","affiliation":[{"name":"Pediatric Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Sagcan","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begumhan D.","family":"Gundugan","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevcan T.","family":"Bozdogan","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Cukurova University Faculty of Medicine, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda B.","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Avci","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuksel","family":"Balci","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin Y.","family":"Karabulut","sequence":"additional","affiliation":[{"name":"Pathology, Mersin University Faculty of Medicine, Mersin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"R1-20260901","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jmedgenet-2018-105664","article-title":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy","volume":"56","author":"Suerink","year":"2019","journal-title":"J Med Genet"},{"key":"R2-20260901","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","article-title":"Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood","volume":"23","author":"Tabori","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R3-20260901","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MPH.0000000000000632","article-title":"Outcome of nephroblastoma treatment according to the SIOP-2001 strategy at a single institution in Argentina","volume":"39","author":"Cafferata","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-20260901","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00412-015-0514-0","article-title":"New insights into the mechanism of DNA mismatch repair","volume":"124","author":"Reyes","year":"2015","journal-title":"Chromosoma"},{"key":"R5-20260901","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/cr0404794","article-title":"DNA mismatch repair: functions and mechanisms","volume":"106","author":"Iyer","year":"2006","journal-title":"Chem Rev"},{"key":"R6-20260901","doi-asserted-by":"crossref","first-page":"35458","DOI":"10.18632\/oncotarget.26249","article-title":"Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies","volume":"9","author":"Abedalthagafi","year":"2018","journal-title":"Oncotarget"},{"key":"R7-20260901","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cge.12904","article-title":"Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1","volume":"91","author":"Wimmer","year":"2017","journal-title":"Clin Genet"},{"key":"R8-20260901","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cge.13053","article-title":"Constitutional mismatch repair deficiency in a healthy child: on the spot diagnosis?","volume":"93","author":"Suerink","year":"2018","journal-title":"Clin Genet"},{"key":"R9-20260901","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00439-002-0858-4","article-title":"Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type","volume":"112","author":"Wang","year":"2003","journal-title":"Hum Genet"},{"key":"R10-20260901","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/pbc.25818","article-title":"Constitutional mismatch repair deficiency in Israel: high proportion of founder mutations in MMR genes and consanguinity","volume":"63","author":"Baris","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20260901","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium \u2018care for CMMRD\u2019 (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J Med Genet"},{"key":"R12-20260901","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00439-008-0542-4","article-title":"Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?","volume":"124","author":"Wimmer","year":"2008","journal-title":"Hum Genet"},{"key":"R13-20260901","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3324\/haematol.2009.021626","article-title":"Constitutional mismatch repair-deficiency syndrome","volume":"95","author":"Wimmer","year":"2010","journal-title":"Haematologica"},{"key":"R14-20260901","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","volume":"66","author":"M\u00f8ller","year":"2017","journal-title":"Gut"},{"key":"R15-20260901","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cge.12526","article-title":"Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population","volume":"87","author":"Castellsague","year":"2015","journal-title":"Clin Genet"},{"key":"R16-20260901","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1086\/421332","article-title":"Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history","volume":"74","author":"Buttin","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R17-20260901","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41431-018-0197-0","article-title":"Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)","volume":"26","author":"Leenders","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"R18-20260901","first-page":"1","article-title":"The role of DNA mismatch repair in drug resistance","volume":"4","author":"Fink","year":"1998","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000001687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:04:23Z","timestamp":1788282263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000001687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001687","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"2019-09-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}